Regulatory T Cells and Profile of FOXP3 Isoforms Expression in Peripheral Blood of Patients with Myelodysplastic Syndromes
Table 2
The characteristics of patients with MDS.
Parameter
Patients with MDS, n=76
Frequency, %
Age, years
69 (63–76)
-
Sex
Male
35
46.1 34.8; 57.3
Female
41
53.9 42.7; 65.2
MDS variant (WHO2008)
RA1
14
18.4 9.7; 27.1
MDS associated with isolated
6
7.9 1.8; 14.0
del(5q)
5
6.6 1.0; 12.2
RARS2
17
22.4 13.0; 31.7
RCMD3
15
19.7 10.8; 28.7
RAEB4-1
19
25.0 15.3; 34.7
RAEB-2
Karyotype
Normal
48
63.2 52.3; 74.0
Abnormal
28
36.8 26.0; 47.7
IPSS
Low
19
25.0 15.3; 34.7
Intermediate-1
12
15.8 7.6; 24.0
Intermediate-2
19
25.0 15.3; 34.7
High
26
34.2 23.5; 44.9
Note: The karyotype changes are described in the text. 1RA, refractory anemia; RARS, refractory anemia with ring sideroblasts; RCMD, refractory cytopenia with multilineage dysplasia; RAEB, refractory anemia with excess blasts.